HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Penicillin and vancomycin tolerance among clinical isolates of Streptococcus pneumoniae in Hong Kong.

AbstractOBJECTIVE:
To determine the prevalence of penicillin and vancomycin tolerance in clinical isolates of Streptococcus pneumoniae.
DESIGN:
Laboratory testing of 50 consecutive clinical isolates.
SETTING:
District hospital, Hong Kong.
PATIENTS:
Fifty patients with pneumonia or meningitis who were admitted to a district hospital in Hong Kong between August and October 2002.
MAIN OUTCOME MEASURES:
Lysis, as assessed by loss of optical density at 4 hours at 540 nm, and reduction in viable count expressed as the log of the number killed ('log kill') after exposure of cultures to 10 times the minimum inhibitory concentration of penicillin and vancomycin.
RESULTS:
Of the 50 isolates, five (10%) were tolerant to penicillin and one (2%) was tolerant to vancomycin.
CONCLUSION:
This is the first report of vancomycin tolerance in Streptococcus pneumoniae in Hong Kong. Because vancomycin tolerance is associated with clinical failure in the treatment of pneumococcal meningitis, increased monitoring for resistant strains of organisms is suggested.
AuthorsM V Boost, W M Ko, M M O'Donoghue
JournalHong Kong medical journal = Xianggang yi xue za zhi (Hong Kong Med J) Vol. 9 Issue 6 Pg. 415-8 (Dec 2003) ISSN: 1024-2708 [Print] China
PMID14660808 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Penicillins
  • Vancomycin
Topics
  • Drug Tolerance
  • Hong Kong (epidemiology)
  • Humans
  • Microbial Sensitivity Tests
  • Penicillins (pharmacology)
  • Pneumococcal Infections (drug therapy, epidemiology)
  • Streptococcus pneumoniae (drug effects, isolation & purification)
  • Vancomycin (pharmacology)
  • Vancomycin Resistance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: